- Home
- AFBI vs ATRA Comparison
AFBI vs ATRA Comparison
Compare AFBI & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AFBI | ATRA |
|---|---|---|
| Founded | 1928 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.6M | 99.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | AFBI | ATRA |
|---|---|---|
| Price | $20.02 | $14.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 6.9K | ★ 63.3K |
| Earning Date | 10-24-2025 | 11-12-2025 |
| Dividend Yield | ★ 7.49% | N/A |
| EPS Growth | ★ 37.47 | N/A |
| EPS | 1.17 | ★ 1.97 |
| Revenue | $31,784,000.00 | ★ $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.14 | ★ $7.29 |
| Revenue Growth | 3.87 | ★ 51.27 |
| 52 Week Low | $17.00 | $5.01 |
| 52 Week High | $22.50 | $18.71 |
Technical Indicators
Market Signals| Indicator | AFBI | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 53.90 |
| Support Level | $18.61 | $12.05 |
| Resistance Level | $20.25 | $15.12 |
| Average True Range (ATR) | 0.20 | 1.06 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 85.98 | 70.59 |
Price Performance
Historical ComparisonAbout AFBI Affinity Bancshares Inc. (MD)
Affinity Bancshares Inc is a holding company of Affinity Bank, a federally chartered stock savings bank that offers a variety of deposit accounts, including checking accounts, savings accounts, and certificate of deposit accounts. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate loans, commercial and industrial loans, residential real estate loans, construction and land loans, and consumer loans. It also invests in securities, which consist of mortgage-backed securities and obligations issued by United States government-sponsored enterprises and Federal Home Loan Bank stock.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).